Effect of Adriamycin on the Cell Cycle Traverse and Kinetics of Cultured Human Lymphoblasts

Awtar Krishan, Emil Frei

Research output: Contribution to journalArticle

107 Scopus citations

Abstract

Exposure of cultured human lymphoblasts to adriamycin (ADM) (0.1 μg/ml for 24 hr or 0.5 μg/ml for 1 hr) leads to an accumulation of cells with the DNA content of late S and G2. Higher concentrations of ADM (0.5 to 10 μg/ml) inhibit cell cycle traverse. Effect of ADM on cell cycle traverse, cell growth, and incorporation of labeled precursors into DNA is dependent on drug concentration and length of exposure to ADM. Synchronized cells in G1 or G2 part of the cell cycle are less sensitive to ADM than cells in S phase. Similarly, plateau phase cells are less sensitive to ADM than cells from log phase cultures.

Original languageEnglish (US)
Pages (from-to)143-150
Number of pages8
JournalCancer Research
Volume36
Issue number1
StatePublished - Jan 1976

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Effect of Adriamycin on the Cell Cycle Traverse and Kinetics of Cultured Human Lymphoblasts'. Together they form a unique fingerprint.

  • Cite this